SCIENTURE HOLDINGS, INC. Gain (Loss) on Disposition of Assets
SCIENTURE HOLDINGS, INC. (SCNX) reported Gain (Loss) on Disposition of Assets of -$374.97 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Other Income
us-gaap:GainLossOnDispositionOfAssets1 · last filed 2026-03-30
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for the quarter ending 2024-12-31 was $0.00.
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for the quarter ending 2024-09-30 was $0.00.
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for the quarter ending 2024-06-30 was $0.00.
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for the quarter ending 2024-03-31 was -$374.97K.
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for fiscal 2024 was -$374.97K.
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for fiscal 2023 was -$2.80M, a 127325.82% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. gain (loss) on disposition of assets for fiscal 2022 was $2.20K.
| Period end | Gain (Loss) on Disposition of Assets 3 month | Gain (Loss) on Disposition of Assets 6 month | Gain (Loss) on Disposition of Assets 9 month | Gain (Loss) on Disposition of Assets 9 month as first filed | Gain (Loss) on Disposition of Assets 12 month | Gain (Loss) on Disposition of Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $0.00 derived: sum of 2 quarters · filed 2026-03-30 | $0.00 derived: sum of 3 quarters · filed 2026-03-30 | -$374.97K 10-K · filed 2026-03-30 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | -$374.97K 10-Q · filed 2025-11-12 | |||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$374.97K 10-Q · filed 2025-08-12 | ||||
| 2024-03-31 | -$374.97K 10-Q · filed 2024-06-26 | |||||
| 2023-12-31 | -$2.80M 10-K · filed 2025-03-26 | |||||
| 2023-03-31 | -$352.24K 10-Q · filed 2024-06-26 | -$352.24K derived: sum of 2 quarters · filed 2024-06-26 | -$354.14K derived: sum of 3 quarters · filed 2024-06-26 | -$354.14K derived: sum of 4 quarters · filed 2024-06-26 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | -$1.90K derived: sum of 2 quarters · filed 2024-04-22 | -$1.90K derived: sum of 3 quarters · filed 2024-04-22 | $2.20K 10-K · filed 2024-04-22 | $4.10K 10-K · filed 2023-03-27 | |
| 2022-09-30 | -$1.90K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-01-16 | -$1.90K derived: sum of 2 quarters · filed 2024-01-16 | $2.20K 10-Q · filed 2024-01-16 | $4.10K 10-Q · filed 2022-11-07 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-18 | $4.10K 10-Q · filed 2023-08-18 | ||||
| 2022-03-31 | $4.10K 10-Q · filed 2023-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |